Skip to search formSkip to main contentSkip to account menu

Cellcept

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Background: Mycophenolate mofetil (MMF, CellCept®) has been utilized as an antirejection agent in transplant recipients and in… 
2010
2010
Background: Mycophenolate mofetil (MMF) is an oral DNA base synthesis inhibitor with immunomodulatory effects on B cells, T cells… 
Highly Cited
2009
Highly Cited
2009
Background Mycophenolic acid (MPA) is an immunosuppressant drug commonly used in patients undergoing solid organ transplant… 
Highly Cited
2007
Highly Cited
2007
Abstract:  Background:  Maintenance steroid therapy is associated with significant morbidity and mortality in renal transplant… 
2007
2007
To determine the safety of a combination of mycophenolate mofetil (Cellcept®, MMF) and IFNβ‐1a (Avonex®) in relapsing‐remitting… 
2007
2007
BACKGROUND Simultaneous pancreas-kidney (SPK) transplantation is an effective treatment for patients suffering from type 1… 
2004
2004
Purpose: Inosine monophosphate dehydrogenase (IMPDH) inhibitors have been used to induce leukemia blast cell differentiation but… 
Highly Cited
2002
Highly Cited
2002
Background: Previous studies indicate that obesity is a risk factor in renal transplantation. However, these analyses did not… 
Review
2001
Review
2001
Mycophenolate mofetil (MMF, CellCept), a semisynthetic derivative of mycophenolic acid (MPA) produced by a fungus, is an…